Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015)
Voyager Therapeutics (VYGR) posted Preferred Dividend Payments of $1.3 million for Q4 2015, down 48.8% sequentially from $2.6 million in Q3 2015, and up 161.93% YoY from $507000.0 in Q4 2014.
Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Voyager Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $1.3 million in Q4 2015.
- Quarterly Preferred Dividend Payments rose 161.93% year-over-year to $1.3 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $5.3 million (changed N/A YoY) and the FY2016 annual result came in at $1.2 million, down 83.72% from the prior year.
- Preferred Dividend Payments declined to $1.3 million in Q4 2015 per VYGR's latest filing, from $2.6 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $2.6 million in Q3 2015 and troughed at $399000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.33 Mn |
| Sep 30, 2015 | 2.59 Mn |
| Jun 30, 2015 | 399,000.00 |
| Mar 31, 2015 | 999,000.00 |
| Dec 31, 2014 | 507,000.00 |
| Sep 30, 2014 | 406,000.00 |